|Title:||Update: Arkansas Medicaid DUR Board - July 15, 2020|
UPDATE: With continued social distancing recommendations due to COVID-19, the DUR Board meeting will again be held in a virtual format. The Arkansas Medicaid Drug Utilization Review Board will be conducting a ZOOM webinar to facilitate our upcoming meeting. Below you will find a link to register for the webinar. This is a public meeting, and invitations to the public have been sent using our current list of interested parties. This list includes industry representatives and members of the media. All public attendees will be muted and will be unable to make comments. Only Board members, DHS staff and pre-determined speakers will be allowed to make comments.
The meeting will take place at the normal time of 8:30 a.m-12:30 p.m. on July 15, 2020.
Each person attending the meeting must register at the link below.
INVITATION FOR ATTENDEES TO REGISTER:
You are invited to a Magellan Health webinar.
When: July 15, 2020 8:30 AM Central Time
Topic: Arkansas Medicaid DUR Quarterly Board Meeting
Please register for the date and time that works best for you:
After registering, you will receive a confirmation email containing information about joining the webinar
Thank you in advance for you attendance.
For those drug companies that have a drug listed on the agenda and wish to submit a request to make public comments on your drug, the deadline to submit the request with the required data is by close of business. The documentation provided will be forwarded to our Board members prior to the meeting. Please provide the following per the current DUR bylaws:
Please do not submit a copy of the drug’s package insert in lieu of the public comments as we already have copies of all of the drug package inserts. As a reminder, the total comment time is 6 minutes per drug. If there is more than one speaker for the same drug, the speakers must split the 6 minute total comment time, and of the public comments applies to every speaker for the drug.
A copy of the proposed criteria for the specific agenda item on which an individual requests to speak may be requested from the Chairperson three (3) weeks prior to the DUR Board meeting. The information will be in draft form and may be changed by the DUR Board prior to being finalized. As such, the draft criteria should be shared with clinicians or patients.
Interested parties for products or topics listed on the quarterly meeting agenda may reach out to the Arkansas Medicaid Pharmacy Program after the agenda is posted to request a meeting with staff prior to the DUR Board meeting. These meetings may be held in-person or by conference call up to three (3) weeks prior to the DUR meeting and shall be no longer than in duration. These meetings will be disclosed to the DUR Board, along with any written materials provided in the meetings, as part of the information provided to members two (2) weeks prior to the quarterly meeting.
At this time, a decision has not been made concerning the meeting location/format. Once a decision is made, all interested parties will be notified.
Cindi Pearson, Pharm. D.
DMS/Arkansas Medicaid Pharmacy Program